This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Elsevier Evidence-based Medicine Center Selects Doctor Evidence For Digital Clinical Evidence Platform

PHILADELPHIA, July 23, 2014 /PRNewswire/ --

Doctor Evidence to provide a comprehensive clinical evidence platform to support Elsevier Clinical Solutions' global clinical product suite 

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that Elsevier Clinical Solutions' Evidence-based Medicine Center (EBM Center) has reached an agreement with Doctor Evidence LLC (DRE) to provide the platform engine supporting the Clinical Solutions' suite of evidence-based clinical solutions.

"Doctor Evidence is tremendously excited to be working with the Elsevier EBM Center in providing physicians and patients with truly evidence-based clinical data," said Robert Battista, CEO and Co-Founder of Doctor Evidence. "Consistent with our company values, the most gratifying partnerships are the ones that have the potential to directly impact patients and improve their outcomes and well-being through the use of evidence. This engagement with the Elsevier EBM Center is one of those partnerships."

DRE will configure databases with high quality data from the medical literature pertinent to key clinical topics for the EBM Center, assuring that all the information is reliably and easily managed through a robust technology platform that is compliant with the standards set forth by the world's leading authorities on evidence-based medicine. DRE's Digital Outcome Conversion (DOCâ„¢) suite of products will provide the evidence foundation supporting Elsevier solutions such as ClinicalKey, InOrder by Elsevier, and other point-of-care decision support resources.

"Our suite of clinical solutions addresses some of the biggest challenges in healthcare by making clinical evidence available to professionals and patients at the right time and in the right setting," said David Goldmann, MD, Vice President and Chief Medical Quality Assurance Officer at Elsevier Clinical Solutions. Goldmann heads up the EBM Center.

"The EBM Center is charged with ensuring that Elsevier's clinical content is as high-quality and evidence-based as it can be. Among the many companies claiming to be able to meet our needs for extracting and synthesizing clinical data to support our activities, Doctor Evidence stands alone with its combination of people, process and technology," Goldmann said. "Doctor Evidence's platform will allow our team of methodologists and subject matter experts to conduct powerful analyses and to continually update the body of evidence supporting our clinical products."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 0.00%
GOOG $695.70 0.00%
FB $118.06 0.00%
TSLA $222.56 0.00%
YHOO $36.00 0.00%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs